Hugh Gelabert, MD
Dr. Gelabert is a Professor of Surgery in the Vascular and Endovascular Division at the David Geffen UCLA School of Medicine. His clinical interest is in General Vascular Surgery, with special interest in Aortic Aneurysm disease, Dialysis Access, and Thoracic Outlet Syndrome. A graduate from Georgetown University and the Sydney Kimmel Thomas Jefferson Medical College, he trained as a General Surgeon at the Eastern Virginia Graduate School of Medicine. He completed Vascular Surgery Fellowship and Liver Transplantation Fellowship training at UCLA, and has been a member of the UCLA Surgery Faculty since1991. He maintains current Board Certification in Vascular Surgery, and additional certification in Vascular Ultrasound technology (RVT). His clinical appointments include the Ronald Regan, Santa Monica UCLA and the West Los Angeles Veterans Administration Medical Centers. As an academic researcher, he has been an investigator for several Aortic Aneurysm trials including ADAM, OVER, ANCONDA. He is currently one of the principal investigators for the BEST CLI NIH sponsored Trial. In his clinical practice, he has been recognized as a leader in Dialysis access surgery, including hemodialysis, AV fistula creation, and peritoneal dialysis. He has received recognition and awards for his care of dialysis patients. Dr. Gelabert is widely recognized as an authority in Thoracic Outlet Syndrome (TOS). He has presented multiple Regional, National, and International lectures on TOS. He is a collaborator on national and international TOS research. He is a co-editor of the leading TOS textbook and has written extensively in this area. A native of Puerto Rico with a bi-cultural background, Dr.Gelabert is a native Spanish and English speaker. Dr. Gelabert has been recognized as one of the Los Angeles Top Doctors in 2018, 2019, and 2020.